Загрузка видео...

Не удалось загрузить видео

На главную

The ECLIPSE Trial has completed enrollment with the randomization of 2000 patients. Dr. Philippe Généreux and I discuss the design of the trial in which vessel preparation strategies are compared in severely calcified coronary artery lesions.

CMichaelGibson's profile picture

C. Michael Gibson MD

430,270 subscribers

15,029 просмотров • 2 лет назад •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 1

Фото профиля David Bartov
David Bartov2 лет назад

@CardiacConsult Very informative interview, can’t wait to see the results.

Похожие видео

In the ShortCUT trial, the WOLVERINE™ Cutting Balloon delivers comparable safety, proven efficacy, and total procedural cost savings compared to current US market IVL for calcified coronary lesions. Explore the data: WOLVERINE™ Coronary Cutting Balloon™ Indications, Safety, and Warnings:
0:30

In the ShortCUT trial, the WOLVERINE™ Cutting Balloon delivers comparable safety, proven efficacy, and total procedural cost savings compared to current US market IVL for calcified coronary lesions. Explore the data: WOLVERINE™ Coronary Cutting Balloon™ Indications, Safety, and Warnings:

BostonSci Cardiology

13,479 просмотров • 4 месяцев назад

What is the appropriate antithrombotic regimen for patients with chronic coronary syndrome who are at high atherothrombotic risk and receiving long-term oral anticoagulation? View the full results of the AQUATIC trial:
1:20

What is the appropriate antithrombotic regimen for patients with chronic coronary syndrome who are at high atherothrombotic risk and receiving long-term oral anticoagulation? View the full results of the AQUATIC trial:

NEJM

16,263 просмотров • 7 месяцев назад

The #ECLIPSE trial presented by Ajay Kirtane at #TCT2024 showed that there was no difference between orbital atherectomy and POBA for severely calcified lesions. So I'm posting this clip from my four decades ago 1985 interview with Andreas Gruentzig about "The Ideal Catheter." He says: "For most of our problems at the present time, the balloon catheter is quite a good answer." #AngioHistory
2:16

The #ECLIPSE trial presented by Ajay Kirtane at #TCT2024 showed that there was no difference between orbital atherectomy and POBA for severely calcified lesions. So I'm posting this clip from my four decades ago 1985 interview with Andreas Gruentzig about "The Ideal Catheter." He says: "For most of our problems at the present time, the balloon catheter is quite a good answer." #AngioHistory

Angioplasty.Org

29,868 просмотров • 1 год назад

The latest video in our partnership with Dr. Glaucomflecken summarizes the results of the VANISH2 trial, which compared catheter ablation versus antiarrhythmic drug therapy for ventricular tachycardia. View the full article for free:
1:24

The latest video in our partnership with Dr. Glaucomflecken summarizes the results of the VANISH2 trial, which compared catheter ablation versus antiarrhythmic drug therapy for ventricular tachycardia. View the full article for free:

NEJM

50,295 просмотров • 1 год назад

In the latest video in our partnership with Dr. Glaucomflecken, the BALANCE trial comparing 7 days of antibiotic treatment with 14 days of treatment in patients with bloodstream infection is explained. Access the article for free:
1:28

In the latest video in our partnership with Dr. Glaucomflecken, the BALANCE trial comparing 7 days of antibiotic treatment with 14 days of treatment in patients with bloodstream infection is explained. Access the article for free:

NEJM

88,397 просмотров • 11 месяцев назад

Our latest video in our partnership with Dr. Glaucomflecken summarizes a trial assessing the efficacy and safety of intravenous tenecteplase for acute central retinal artery occlusion. Read the full study for free:
1:17

Our latest video in our partnership with Dr. Glaucomflecken summarizes a trial assessing the efficacy and safety of intravenous tenecteplase for acute central retinal artery occlusion. Read the full study for free:

NEJM

33,682 просмотров • 1 месяц назад

In the latest video in our partnership with Dr. Glaucomflecken, the REGENCY trial investigating the efficacy and safety of obinutuzumab when added to standard therapy in patients with active proliferative lupus nephritis is explained. Access the article for free:
1:46

In the latest video in our partnership with Dr. Glaucomflecken, the REGENCY trial investigating the efficacy and safety of obinutuzumab when added to standard therapy in patients with active proliferative lupus nephritis is explained. Access the article for free:

NEJM

144,730 просмотров • 11 месяцев назад

Our latest video in our partnership with Dr. Glaucomflecken explains the results of the RESHAPE-HF2 trial investigating whether transcatheter mitral-valve repair improves outcomes in patients with heart failure and functional mitral regurgitation.
1:30

Our latest video in our partnership with Dr. Glaucomflecken explains the results of the RESHAPE-HF2 trial investigating whether transcatheter mitral-valve repair improves outcomes in patients with heart failure and functional mitral regurgitation.

NEJM

98,901 просмотров • 1 год назад

#ACC2025 Obesity Wrap Up: Dr. Belardo and I discuss the PRAGUE-25 trial (catheter ablation vs. antiarrhythmics with weight management and lifestyle alterations in AF), SOUL trial (oral semaglutide vs. placebo in DM with ASCVD/CKD), STRIDE trial (semaglutide vs. placebo in DM with PAD), EKSTROM trial (colchicine vs. placebo in stable CAD), and WARRIOR trial (intensive medical therapy vs. usual care in women with INOCA).
18:16

#ACC2025 Obesity Wrap Up: Dr. Belardo and I discuss the PRAGUE-25 trial (catheter ablation vs. antiarrhythmics with weight management and lifestyle alterations in AF), SOUL trial (oral semaglutide vs. placebo in DM with ASCVD/CKD), STRIDE trial (semaglutide vs. placebo in DM with PAD), EKSTROM trial (colchicine vs. placebo in stable CAD), and WARRIOR trial (intensive medical therapy vs. usual care in women with INOCA).

C. Michael Gibson MD

18,102 просмотров • 1 год назад

Internal Medicine rounds are never “aggressively boring” with Dr. G. Watch the latest video in which Dr. Glaucomflecken summarizes the PICNIC trial. Access the article for free:
1:39

Internal Medicine rounds are never “aggressively boring” with Dr. G. Watch the latest video in which Dr. Glaucomflecken summarizes the PICNIC trial. Access the article for free:

NEJM

92,472 просмотров • 1 год назад

Our latest video in our partnership with Dr. Glaucomflecken summarizes the POTCAST trial, which assessed a strategy of actively increasing plasma potassium levels to the high-normal range in patients at high risk for ventricular arrhythmias. Read the full study for free:
1:27

Our latest video in our partnership with Dr. Glaucomflecken summarizes the POTCAST trial, which assessed a strategy of actively increasing plasma potassium levels to the high-normal range in patients at high risk for ventricular arrhythmias. Read the full study for free:

NEJM

89,707 просмотров • 4 месяцев назад

#BBCQuitIndia Okay Quitting today BJP and Modi should face trial in international court of Justice for #Godhra massacre and #GujaratRiots in which over 2000 minorities were killed with the help of state
0:25

#BBCQuitIndia Okay Quitting today BJP and Modi should face trial in international court of Justice for #Godhra massacre and #GujaratRiots in which over 2000 minorities were killed with the help of state

Anil Cherukara I.N.D.I.A

78,187 просмотров • 3 лет назад

#KimKardashian's robbery trial is in full swing in Paris. The cast of #TMZonTV discuss!
0:24

#KimKardashian's robbery trial is in full swing in Paris. The cast of #TMZonTV discuss!

TMZ

26,483 просмотров • 1 год назад

In preparation for the start of his public trial, the criminal Atef Najib appeared in the defendant’s dock before the #Criminal Court at the Palace of #Justice in #Damascus.
0:42

In preparation for the start of his public trial, the criminal Atef Najib appeared in the defendant’s dock before the #Criminal Court at the Palace of #Justice in #Damascus.

Qusay Noor

84,911 просмотров • 1 месяц назад

Our latest video in our partnership with Dr. Glaucomflecken summarizes a new trial investigating the mass administration of ivermectin for reducing malaria transmission. Read the full results of the BOHEMIA trial for free:
1:14

Our latest video in our partnership with Dr. Glaucomflecken summarizes a new trial investigating the mass administration of ivermectin for reducing malaria transmission. Read the full results of the BOHEMIA trial for free:

NEJM

19,398 просмотров • 6 месяцев назад

In an international, randomized trial involving patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during the 3-month treatment period. Full COBRRA trial results and Research Summary:
0:58

In an international, randomized trial involving patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during the 3-month treatment period. Full COBRRA trial results and Research Summary:

NEJM

12,209 просмотров • 2 месяцев назад

Dr. Saibal Kar and Dr. C. Michael Gibson discuss the CHAMPION-AF trial: Left atrial appendage closure with the WATCHMAN FLX device was non-inferior to DOACs for the composite of CV death, stroke, or systemic embolism among patients with non-valvular AFib. #ACC26 Watch video here:
14:13

Dr. Saibal Kar and Dr. C. Michael Gibson discuss the CHAMPION-AF trial: Left atrial appendage closure with the WATCHMAN FLX device was non-inferior to DOACs for the composite of CV death, stroke, or systemic embolism among patients with non-valvular AFib. #ACC26 Watch video here:

C. Michael Gibson MD

10,718 просмотров • 2 месяцев назад

Ex-Minister Mohibul Hasan on Hasina verdict "Staged drama in the name of a trial. The whole process was illegal" Yunus turning "Bangladesh into a vessel state of ISI" "party which brought the country's freedom has been banned" Interview:
13:00

Ex-Minister Mohibul Hasan on Hasina verdict "Staged drama in the name of a trial. The whole process was illegal" Yunus turning "Bangladesh into a vessel state of ISI" "party which brought the country's freedom has been banned" Interview:

Sidhant Sibal

34,947 просмотров • 6 месяцев назад

In a trial of patients with bifurcation lesions, main branch stenting and POT, ending the procedure with no further intervention was noninferior to POT-side-POT or kissing balloon inflation for myocardial injury or infarction, and less likely required a second stent. #EuroPCR
1:46

In a trial of patients with bifurcation lesions, main branch stenting and POT, ending the procedure with no further intervention was noninferior to POT-side-POT or kissing balloon inflation for myocardial injury or infarction, and less likely required a second stent. #EuroPCR

PCRonline 🫀

30,999 просмотров • 3 лет назад

For patients with generalized myasthenia gravis, existing treatments reduce mortality and alleviate symptoms, but side effects and poor efficacy leave many patients seeking alternatives. The latest video in our partnership with Dr. Glaucomflecken summarizes the MINT trial. 👉
1:40

For patients with generalized myasthenia gravis, existing treatments reduce mortality and alleviate symptoms, but side effects and poor efficacy leave many patients seeking alternatives. The latest video in our partnership with Dr. Glaucomflecken summarizes the MINT trial. 👉

NEJM

137,306 просмотров • 9 месяцев назад